Interleukin-8: More on the mechanisms of progenitor cells mobilization in acute coronary syndromes

European Heart Journal

Volumn 27, Issue 9, 2006, Pages 1013-1015

  Wojakowski, Wojciech ^a   Ratajczak, Mariusz Z ^b   Tendera, Michał ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; INTERLEUKIN 8;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; BONE MARROW; BONE MARROW CELL; CELL TRANSFORMATION; EDITORIAL; HEMATOPOIETIC STEM CELL; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; STEM CELL; STEM CELL MOBILIZATION;

ANTIGENS, CD; GLYCOPROTEINS; HEMATOPOIETIC STEM CELL MOBILIZATION; INTERLEUKIN-8; MYOCARDIAL INFARCTION; PEPTIDES; STEM CELLS;

EID: 33646253456     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi889     Document Type: Editorial

References (10)

1. Schömig K, Busch G, Steppich B, Sepp D, Kaufmann J, Stein A, Schömig A, Ott I. Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarction. Eur Heart J 2006;27:1032-1037. First published on February 2, 2006, doi:10.1093/eurheartj/ehi761.
2. Urbich C, Dimmeler S. Endothelial progenitor cells characterization and role in vascular biology. Circ Res 2004;95:343.
3. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, Sasaki K, Shimada T, Oike Y, Imaizumi T. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001;103:2776-2779.
4. Massa M, Rosti V, Ferrario M, Campanelli R, Ramajoli I, Rosso R, De Ferrari GM, Ferlini M, Goffredo L, Bertoletti A, Klersy C, Pecci A, Moratti R, Tavazzi L. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005;105:199-206.
5. George J, Goldstein E, Abashidze S, Deutsch V, Shmilovich H, Finkelstein A, Herz I, Miller H, Keren G. Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. Eur Heart J 2004;25:1003-1008.
6. Werner N, Nickenig G. Influence of cardiovascular risk factors on endothelial progenitor cells limitations for therapy? Arterioscler Thromb Vasc Biol 2006;26:257.
7. Kucia M, Reca R, Jala VR, Dawn B, Ratajczak J, Ratajczak MZ. Bone marrow as a home of heterogenous populations of non-hematopoietic stem cells. Leukemia 2005;19:1118-1127.
8. Wojakowski W, Tendera M, Michalowska A, Majka M, Kucia M, Maslankiewicz K, Wyderka R, Ochala A, Ratajczak MZ. Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 2004;16:3213-3220.
9. Kucia M, Zhang YP, Reca R, Wysoczynski M, Machalinski B, Majka M, Ildstad ST, Ratajczak J, Shields CB, Ratajczak MZ. Cells enriched in markers of neural tissue-committed stem cells reside in the bone marrow and are mobilized into the peripheral blood following stroke. Leukemia 2006;20:18-28. doi:10.1038/sj.leu.2404011.
10. Paczkowska E, Larysz B, Rzeuski R, Karbicka A, Jalowinski R, Kornacewicz-Jach Z, Ratajczak MZ, Machalinski B. Human hematopoietic stem/progenitor-enriched CD34(+) cells are mobilized into peripheral blood during stress related to ischemic stroke or acute myocardial infarction. Eur J Haematol 2005;75:461-467.